Towards Healthcare
Animal Biotechnology Market Surging to USD 30.97 Billion by 2025

Animal Biotechnology Market Growth is Fueled by AI, CRISPR and Ethical Farming

According to forecasts, the global animal biotechnology  market will grow from USD 28.17 billion in 2024 to USD 72.6 billion by 2034, with an expected CAGR of 9.93%. The animal biotechnology market is growing significantly due to growing research and development. North America leads the market due to rising collaborations among key market players.

Content

  • Insight Code: 5849
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The animal biotechnology market is projected to reach USD 72.6 billion by 2034, growing at a CAGR of 9.93% from 2024 to 2034.

North America is currently leading the animal biotechnology market due to the presence of the largest biotechnology industry that constantly conducts research for the overall improvement of healthcare and animal-related services.

The animal biotechnology market includes 6 segments such as by product type, by application, by animal type, by end-user, by technology, and by region.

Some key players include Zoetis Inc., Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Bayer Animal Health (Now part of Elanco), etc.

Key trends include rising domestication of animals, consumption of animals, and growing demand for transgenic animal research.

The primary contribution of biotechnology to livestock production is the use of various chemicals, such as feed additives, to improve the digestibility of low-quality feeds, such as roughage, and the nutritional value and content of animal diets.

Molecular biology techniques are employed in animal biotechnology to genetically engineer (i.e., alter the genome of) animals to make them more suitable for use in industrial, medicinal, or agricultural settings.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions